|
11 |
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Enthalten in Nature medicine Bd. 27, 9.12.2021, Nr. 12, date:12.2021: 2234-2245
|
|
|
|
12 |
HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV
Enthalten in Journal of translational medicine Bd. 9, 27.1.2011, Nr. 1, date:12.2011: 1-10
|
|
|
|
13 |
Improvement of antibody functionality by structure-guided paratope engraftment
Enthalten in Nature Communications Bd. 10, 13.2.2019, Nr. 1, date:12.2019: 1-13
|
|
|
|
14 |
Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk
Enthalten in Molecular medicine Bd. 3, 1.1.1997, Nr. 1, date:1.1997: 23-36
|
|
|
|
15 |
MAdCAM costimulation through Integrin-α4β7 promotes HIV replication
Enthalten in Mucosal immunology Bd. 11, 6.6.2018, Nr. 5, date:9.2018: 1342-1351
|
|
|
|
16 |
Novel vaccine technologies for the 21st century
Enthalten in Nature reviews / Immunology Bd. 20, 11.11.2019, Nr. 2, date:2.2020: 87-88
|
|
|
|
17 |
Pathogenic Mechanisms of HIV Disease: The Role of Viral Replication and Immune Activation
Enthalten in Retrovirology Bd. 2, 8.12.2005, Nr. 1, date:12.2005: 1
|
|
|
|
18 |
Preface: Evolving Ethical Issues Over the Course of the AIDS Pandemic
Enthalten in Public health reviews Bd. 34, 18.4.2017, Nr. 1, date:6.2012: 1-6
|
|
|
|
19 |
The Role of Integrin α4β7 in HIV Pathogenesis and Treatment
Enthalten in Current HIV AIDS reports Bd. 15, 24.2.2018, Nr. 2, date:4.2018: 127-135
|
|
Administration
